Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia (Q40373944)
Jump to navigation
Jump to search
scientific article published on November 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia |
scientific article published on November 2005 |
Statements
1 reference
Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia (English)
1 reference
Hagop Kantarjian
1 reference
Alessandra Ferrajoli
1 reference
Stefan Faderl
1 reference
Srdan Verstovsek
1 reference
Jorge Cortes
1 reference
Susan O'Brien
1 reference
Elias Jabbour
1 reference
Farhad Ravandi
1 reference
Francis Giles
1 reference
Guillermo Garcia-Manero
1 reference
Maher Albitar
1 reference
Mario Sznol
1 reference
Steven Kornblau
1 reference
Deborah Thomas
1 reference
Stanton Gerson
1 reference
Verena Karsten
1 reference
Ann Cahill
1 reference
Karen Yee
1 reference
1 November 2005
1 reference
1 reference
11
1 reference
21
1 reference
7817-7824
1 reference
Identifiers
1 reference
1 reference